Liposomes

  • New Drug

 

  • Specialty Drug / High Barrier Generics

Candidate

Indication

Liposomal Doxorubicin

Breast cancer, Ovarian cancer, AIDS-related Kaposi's sarcoma , multiple myeloma

Liposomal Amphotericin B

Systemic fungal infection

 

  • CDMO